Financial Ratios

INDRAYANI BIOTECH LTD.

NSE : NABSE : 526445ISIN CODE : INE007C01021Industry : FloricultureHouse : Private
BSE57.79-1.23 (-2.08 %)
PREV CLOSE ( ) 59.02
OPEN PRICE ( ) 59.02
BID PRICE (QTY) 57.50 (50)
OFFER PRICE (QTY) 57.79 (49)
VOLUME 14683
TODAY'S LOW / HIGH ( )56.07 59.50
52 WK LOW / HIGH ( ) 46.899.7
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.481.23-3.18-0.56-0.15
   CEPS(Rs)1.751.34-3.06-0.56-0.15
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.797.065.83-2.36-1.80
   Tax Rate(%)0.440.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)11.7110.76-22.22-30.83
   EBIT Margin(%)10.6410.55-42.45-30.83
   Pre Tax Margin(%)6.827.29-51.82-40.96
   PAT Margin (%)6.797.29-51.82-40.96
   Cash Profit Margin (%)8.047.88-49.91-40.96
Performance Ratios
   ROA(%)6.759.47-54.34-181.70-670.67
   ROE(%)15.6719.15-114.060.000.00
   ROCE(%)12.4516.03-50.650.000.00
   Asset Turnover(x)0.991.301.054.440.00
   Sales/Fixed Asset(x)3.423.451.27
   Working Capital/Sales(x)4.58-124.20-7.79-2.970.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.290.290.790.00
   Receivable days71.3155.5342.0955.93
   Inventory Days7.917.7118.830.00
   Payable days35.2545.3644.01142.13
Valuation Parameters
   PER(x)38.2524.700.000.000.00
   PCE(x)32.2922.84-2.07-14.80-47.30
   Price/Book(x)4.794.321.09-3.53-3.89
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.192.061.747.27
   EV/Core EBITDA(x)25.3518.53-8.30-23.59-59.47
   EV/EBIT(x)29.9319.57-4.10-23.59-59.47
   EV/CE(x)2.372.420.9216.54567.01
   M Cap / Sales2.601.801.036.06
Growth Ratio
   Net Sales Growth(%)28.44176.044086.31
   Core EBITDA Growth(%)44.89246.66-2747.04-188.7356.72
   EBIT Growth(%)29.63168.59-5663.44-188.7356.72
   PAT Growth(%)19.67138.81-5197.06-281.1256.51
   EPS Growth(%)19.67138.82-463.93-281.1056.51
Financial Stability Ratios
   Total Debt/Equity(x)0.710.690.77-0.80-0.98
   Current Ratio(x)1.490.970.770.570.30
   Quick Ratio(x)1.440.900.680.570.30
   Interest Cover(x)2.783.24-4.53-3.05-157.75
   Total Debt/Mcap(x)0.180.160.710.230.25

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.